SINGAPORE,, May 3, 2025 / Prnewswire / – Artificial intelligence, or AI, transforms our lives in a dynamic and difficult way, including the ability to create life.
In assisted reproduction, AI and automation tools have taken fertility specialists to new borders in precision, efficiency and personalization with radiant technology with a promise for patients who strive for parenting.
However, a world leader in reproductive medicine has warned of the dangers of “race before the rules” because algorithms and AI codes create new dimensions in fertility health care.
Speaking during the initiative of the Asia-Pacific Congress in 2025 on reproduction (Aspire) Singapore Today, professor Ying Cheong This human connection, confidence, transparency and ethical responsibility must remain “at the heart of what we do” because the fertility clinics are increasingly kissing the technological wonders of AI.
She is a teacher of reproductive medicine at the University of Southampton United Kingdom Where his research interests include uterine health with interdisciplinary collaboration in electronics and IT in the development of clinical tools.
“The tools led by AI offer a promise by validation for example in optimizing ovarian stimulation by predicting patient responses, reducing the risk of ovarian hyperstimulation and improving the yield of oocytes,” said Professor Cheong.
“Automatic learning models help the selection of embryos in order to improve the implantation rates and the success of pregnancy.
“Beyond the laboratory, AI and automation rationalize the workflows of the fertility clinic. Micromanipulation assisted by robotics, incubators improved by AI and non -invasive pre -implanting genetic tests (PGT) are progressing.
“Meanwhile, portable biocatters and intrauterine devices emerge as potential tools integrated into AI for uterine surveillance in real time.”
However, Professor Cheong said that artificial intelligence in assisted reproduction posed a range of questions relating to:
- confidence in clinical tools;
- Confidentiality of data and patient consent;
- Marketing, property and power; And
- Regulatory and ethical parameters.
“AI tools require clinical validation in various populations, and ethical concerns about biases and decision-making must be treated,” she said.
“Technology should complement, and not replace clinical expertise guaranteeing a human approach in a loop. With meticulous validation and ethical monitoring, AI can improve accessibility, affordability and success rates in the treatment of fertility.”
Professor Cheong also stressed the importance of building a social data ecosystem that allows you to share data in a responsible manner, in complete safety and with complete public transparency.
“The trustworthy AI begins with trustworthy data,” she said. “This means models such as a social data foundation where patients, providers and researchers are also collaborating,” she said.
“We must be aware of making access to advanced technology in reproductive medicine accessible for everyone, for example via open access AI platforms and public-private partnerships.
“AI is here now, and we have to adapt quickly. Although it transforms our tools, it should not transform our goal.
“In a global race to build smarter machines, our greatest success will be to remember how to be better humans.”
About 2,000 fertility health experts, including scientists, clinicians, nurses and advisers, attend the congress aspires to the Santec Convention and Exhibition Center in Singapore. For more information, go to www.aspire2025.com
Show original content to download the multimedia:https://www.prnewswire.com/apac/news-releases/a-future-of-reproductive-medicine-Where-humanity-and-trust-in-harmony-with-spectacular-advances-in-artificial-intelligence-3024403.html
Source Asia Pacific Initiative on reproduction
